Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ASPIDIA logo — A biotech startup dedicated to developing innovative microbi...

ASPIDIA

A biotech startup dedicated to developing innovative microbial solutions for the bioremediation of contaminants.

Founded 2021 Italy Italy 2 employees Biotechnology, Health Care

General Information

Company Name ASPIDIA
Founded Year 2021
Location Italy Italy
Employees 2
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with ASPIDIA. To contact ASPIDIA, visit aspidia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ASPIDIA compare?

A PDF of ASPIDIA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ASPIDIA soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ASPIDIA

ASPIDIA is an innovative biotech startup focused on developing microbiological solutions for bioremediation and mucosal delivery. The company offers services for research, optimization, and production of enzymes for industrial processes, including bioremediation. Bioremediation, involving the use of biological agents to degrade contaminants, provides an environmentally friendly and sustainable approach to combat pollution. ASPIDIA is conducting research on finding the most appropriate enzyme(s) to address the degradation of pollutants, including per- and polyfluoroalkyl substances (PFASs). With the use of advanced methodologies such as bioinformatics analysis and in silico modeling, ASPIDIA collaborates with key partners to optimize bioremediation and transformation processes for specific industrial needs. The company's focus on identifying enzymes tailored to specific industrial processes not only aims at reducing operating costs but also enables the implementation of sustainable, green infrastructure at limited fixed costs. In addition to bioremediation, ASPIDIA is conducting scientific research on the use of probiotics as vectors for antigen presentation on mucosal surfaces. This research extends to seek proof-of-principle on a possible new vaccine against COVID-19, and once optimized, this technology could be applied for other antigens and monoclonal antibodies. Founded in 2021 and based in Italy, ASPIDIA presents an intriguing investment opportunity in the biotechnology and health care industries. Considering its innovative approach and potential impact on environmental and healthcare challenges, ASPIDIA is a promising prospect for venture capital investment in the future.

Business keywords: Biotech, Enzymes, Bioremediation, Probiotics, Mucosal Vaccines, Bioinformatics, Industrial Processes, Pollution Remediation, Recombinant Enzymes, Antigen Presentation, Monoclonal Antibodies, COVID-19 Vaccine, Environmental Sustainability, Advanced Microbiological Techniques, Green Infrastructure

No funding data available for ASPIDIA yet.

ASPIDIA Alternatives & Competitors

View All Alternatives
ASPIDIA vs
Dima Biotechnology
Dima Biotechnology United States

Recombinant monoclonal antibodies and membrane proteins for drug discovery.

Angel
6 employees
Biotechnology, Health Care
ASPIDIA vs
The BioCollective
The BioCollective United States

Microbiome innovation made simple - Collect, Connect, Correct.

Grant
6 employees
Big Data, Biotechnology
ASPIDIA vs
Iditarod Bio
Iditarod Bio United States

Iditarod transforms the lung into a metabolic organ.

Seed
5 employees
Biotechnology, Health Care
View all alternatives

FAQ About ASPIDIA

A biotech startup dedicated to developing innovative microbial solutions for the bioremediation of contaminants.
ASPIDIA was founded in 2021.
ASPIDIA is headquartered in Italy.
ASPIDIA operates in Biotechnology and Health Care. Its work centres on Biotech, Enzymes, Bioremediation and Probiotics.
ASPIDIA has approximately 2 employees.
Top alternatives and competitors to ASPIDIA include Dima Biotechnology, The BioCollective, Iditarod Bio, AVESTHAGEN LIMITED, Thermo Fisher Scientific. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ASPIDIA and Dima Biotechnology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ASPIDIA, https://bouncewatch.com/company/aspidia, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes